Gulph Mills, PA, United States of America

John P Yardley



Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 370(Granted Patents)


Location History:

  • Gulph Mills, PA (US) (1985 - 1996)
  • King of Prussia, PA (US) (1976 - 2007)

Company Filing History:


Years Active: 1976-2007

Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Title: John P. Yardley: Innovator in Pharmaceutical Chemistry

Introduction

John P. Yardley, a prominent inventor based in Gulph Mills, Pennsylvania, holds an impressive portfolio of 36 patents. His work focuses primarily on innovative pharmaceutical compounds that contribute to advancements in medicinal chemistry.

Latest Patents

Among Yardley's latest inventions are significant contributions to the field of pharmacology. One of his notable patents is for "Ethers of O-desmethyl venlafaxine". This innovative compound provides O-α-acyloxyalkyl ethers of the venlafaxine metabolite 4-[2-(Dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol, which is represented by a specific formula detailing various variables and configurations at the stereogenic center. Additionally, Yardley has developed "Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity", enhancing the exploration of therapeutic targets in treating various psychiatric disorders.

Career Highlights

Throughout his career, John P. Yardley has made significant contributions while working with renowned companies such as American Home Products Corporation and Wyeth. His dedication to pharmaceutical innovation has positioned him as a valuable asset in the industry.

Collaborations

Yardley's collaborations with esteemed colleagues have further enriched his research and development efforts. Notable coworkers include Magid A. Abou-Gharbia and Wayne E. Childers, Jr., who have partnered with him in various projects, pushing the boundaries of pharmaceutical science.

Conclusion

John P. Yardley's extensive contributions to medicinal chemistry through his numerous patents illustrate his role as a key innovator in the field. His ongoing research and collaboration with industry leaders continue to foster advancements that benefit healthcare and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…